Abstract IA10: PMN-MDSC and neutrophils: Tale of two cells in cancer

D. Gabrilovich
{"title":"Abstract IA10: PMN-MDSC and neutrophils: Tale of two cells in cancer","authors":"D. Gabrilovich","doi":"10.1158/2326-6074.CRICIMTEATIAACR18-IA10","DOIUrl":null,"url":null,"abstract":"Myeloid cells are a critical component of the tumor microenvironment. In cancer, the myeloid compartment is dramatically affected, which is now considered as one of the major immunological hallmarks of cancer. Accumulation of immunosuppressive macrophages (MΦ), defective dendritic cells (DC) function and expansion of pathologically activated immune suppressive immature myeloid cells – myeloid-derived suppressor cells (MDSC) are major changes in the myeloid compartment in cancer. The total population of MDSC consists of three groups of cells: the most abundant (>75%) immature, pathologically activated neutrophils (PMN-MDSC); the less abundant population of pathologically activated monocytes – (M-MDSC). Tumor associated macrophages (TAM) and DCs can persist in tissues for a long time, whereas PMN-MDSC have short lifespan ( Citation Format: Dmitry I. Gabrilovich. PMN-MDSC and neutrophils: Tale of two cells in cancer [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr IA10.","PeriodicalId":22141,"journal":{"name":"Tackling the Tumor Microenvironment: Beyond T-cells","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tackling the Tumor Microenvironment: Beyond T-cells","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-IA10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Myeloid cells are a critical component of the tumor microenvironment. In cancer, the myeloid compartment is dramatically affected, which is now considered as one of the major immunological hallmarks of cancer. Accumulation of immunosuppressive macrophages (MΦ), defective dendritic cells (DC) function and expansion of pathologically activated immune suppressive immature myeloid cells – myeloid-derived suppressor cells (MDSC) are major changes in the myeloid compartment in cancer. The total population of MDSC consists of three groups of cells: the most abundant (>75%) immature, pathologically activated neutrophils (PMN-MDSC); the less abundant population of pathologically activated monocytes – (M-MDSC). Tumor associated macrophages (TAM) and DCs can persist in tissues for a long time, whereas PMN-MDSC have short lifespan ( Citation Format: Dmitry I. Gabrilovich. PMN-MDSC and neutrophils: Tale of two cells in cancer [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr IA10.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
摘要:PMN-MDSC和中性粒细胞:肿瘤中两种细胞的故事
骨髓细胞是肿瘤微环境的重要组成部分。在癌症中,髓细胞室受到显著影响,这被认为是癌症的主要免疫学标志之一。免疫抑制性巨噬细胞(MΦ)的积累、树突状细胞(DC)功能的缺陷和病理激活的免疫抑制性未成熟骨髓细胞-髓源性抑制细胞(MDSC)的扩增是癌症骨髓腔室的主要变化。MDSC的总细胞群由三组细胞组成:最丰富的(>75%)未成熟的、病理活化的中性粒细胞(PMN-MDSC);较少数量的病理活化单核细胞(M-MDSC)。肿瘤相关巨噬细胞(Tumor associated macrophages, TAM)和dc可在组织中存活较长时间,而PMN-MDSC寿命较短(Citation Format: Dmitry I. Gabrilovich)。PMN-MDSC和中性粒细胞:肿瘤中两种细胞的故事[摘要]。第四届CRI-CIMT-EATI-AACR国际癌症免疫治疗会议:将科学转化为生存;2018年9月30日至10月3日;纽约,纽约。费城(PA): AACR;癌症免疫学杂志2019;7(2增刊):摘要1 - 10。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Tumor Microenvironment: Methods and Protocols Abstract A113: Harnessing lymphoid organ neogenesis as a novel prognostic biomarker and therapeutic target Abstract A072: Calreticulin exposures by malignant blasts correlate with robust anticancer immunity and improved clinical outcome in AML patients Abstract A092: TAM receptors targeting unleashes antileukemic immunity and enables checkpoint blockade leading to eradication of leukemic cells Abstract A070: Virotherapy eradicates established melanoma by reprogramming the tumor microenvironment and engaging the adaptive immunity
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1